Clinical Trial Update: Aflibercept Injection for Proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for aflibercept injection in proliferative diabetic retinopathy shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy
• Vitreous Hemorrhage

Drugs mentioned

• aflibercept injection (aflibercept)

Snippet

Sponsor: University of Oklahoma | Conditions: Vitreous Hemorrhage | Phase 2 | Status: COMPLETED | Results posted: 2017-09-13